We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

125 hedge funds and large institutions have $978M invested in Arena Pharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

188% more call options, than puts

Call options by funds: $47.9M | Put options by funds: $16.6M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

34% more capital invested

Capital invested by funds: $731M → $978M (+$247M)

32% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 19

13% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 40

5% more funds holding

Funds holding: 119 → 125 (+6)

Holders
125
Holders Change
+6
Holders Change %
+5.04%
% of All Funds
2.84%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
25
Increased
45
Reduced
40
Closed
19
Calls
$47.9M
Puts
$16.6M
Net Calls
+$31.3M
Net Calls Change
+$13.6M

Top Buyers

1
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$15.3M
2
DM
Deerfield Management
New York
+$12.8M
3
CS
Credit Suisse
Switzerland
+$7.98M
4
Citadel Advisors
Citadel Advisors
Florida
+$7.45M
5
Invesco
Invesco
Georgia
+$6.3M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$9.39M
2
BIM
Bogle Investment Management
Massachusetts
-$8.96M
3
State Street
State Street
Massachusetts
-$8.76M
4
NI
Numeric Investors
Massachusetts
-$7.03M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
-$6.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
USAA
51
United Services Automobile Association
Texas
$1.61M +$62K +2,178 +5%
EI
52
EAM Investors
California
$1.5M -$1.43M -50,259 -53%
ARTA
53
A.R.T. Advisors
New York
$1.48M +$1.24M +43,629 New
AA
54
ALPS Advisors
Colorado
$1.48M +$1.24M +43,460 New
State of Wisconsin Investment Board
55
State of Wisconsin Investment Board
Wisconsin
$1.34M +$430K +15,101 +62%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$1.23M +$131K +4,600 +15%
RhumbLine Advisers
57
RhumbLine Advisers
Massachusetts
$1.22M -$139K -4,883 -12%
FMBTD
58
First Midwest Bank Trust Division
Illinois
$1.15M +$1.14K +40 +0.1%
UBS Group
59
UBS Group
Switzerland
$1.13M -$220K -7,740 -19%
XSC
60
X-Square Capital
Puerto Rico
$1.1M +$922K +32,355 New
NI
61
Numeric Investors
Massachusetts
$1.09M -$7.03M -246,700 -89%
QI
62
QS Investors
New York
$1.05M – – –
Manulife (Manufacturers Life Insurance)
63
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.04M +$4.79K +168 +0.6%
Principal Financial Group
64
Principal Financial Group
Iowa
$975K +$817K +28,692 New
PVI
65
Pura Vida Investments
New York
$951K -$2.38M -83,717 -75%
ProShare Advisors
66
ProShare Advisors
Maryland
$917K +$62.6K +2,196 +9%
AIG
67
American International Group
New York
$900K +$11.6K +406 +2%
Barclays
68
Barclays
United Kingdom
$798K +$239K +8,380 +55%
PA
69
Perceptive Advisors
New York
$747K +$626K +21,978 New
CCMH
70
Cornerstone Capital Management Holdings
New York
$734K -$2.85K -100 -0.5%
Canada Pension Plan Investment Board
71
Canada Pension Plan Investment Board
Ontario, Canada
$709K +$595K +20,880 New
DMK
72
David M. Knott
$681K +$11.4K +400 +2%
MIM
73
MetLife Investment Management
New Jersey
$635K +$532K +18,691 New
VOYA Investment Management
74
VOYA Investment Management
Georgia
$597K – – –
State Board of Administration of Florida Retirement System
75
State Board of Administration of Florida Retirement System
Florida
$554K +$183K +6,410 +65%
1 2
3
4 5

ARNA Hedge Fund Activity: Q4 2017 in Review

125 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2017, worth a combined $978M — up 34% from $731M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new ARNA positions and 19 closed out — a net gain of 6 holders — while 45 added to existing stakes and 40 trimmed.

The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $15.3M. The largest seller was Renaissance Technologies, cutting an estimated $9.39M.

  • 125 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2017, up from 119 in Q3 2017.
  • Funds reported $978M of Arena Pharmaceuticals Inc stock for Q4 2017, up 34% quarter-over-quarter.
  • 25 funds opened new Arena Pharmaceuticals Inc positions in Q4 2017 and 19 closed out, a net change of +6 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q4 2017 was Alyeska Investment Group, an estimated $15.3M added.
  • The largest Arena Pharmaceuticals Inc seller in Q4 2017 was Renaissance Technologies, an estimated $9.39M sold.

Based on aggregated 13F filings for Q4 2017.